Dravet Syndrome Foundation's Clinical Research Grants fund clinical studies to advance understanding, outcome measures, and treatments for Dravet syndrome.
Funder: Dravet Syndrome Foundation
Due Dates: August 21, 2026 (full application submission deadline)
Funding Amounts: $250,000 total over 2 years; indirect costs capped at 10% of award
Summary: Supports experienced investigators conducting clinical research to advance understanding and treatment of Dravet syndrome.
Key Information: Applications must be submitted by 11:59pm US Pacific Time as PDFs via the online form.
The Clinical Research Grants from the Dravet Syndrome Foundation (DSF) are designed to fund established, independent investigators at academic or research institutions for clinical projects directly related to Dravet syndrome. The grants aim to advance knowledge of Dravet syndrome’s natural history, clinical features, patient outcomes, and comorbidities. Key priorities include research that develops or refines outcome measures, seeks to predict and prevent SUDEP (sudden unexpected death in epilepsy), or fosters the development of novel therapies to halt or prevent disease progression. Projects are evaluated for preliminary data, research design, feasibility, investigator qualifications, and overall impact, ensuring alignment with DSF’s mission to support research for better treatments and a cure.